Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $0.82.

  • Utah Medical Products' EPS (Basic) fell 1960.78% to $0.82 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.54, marking a year-over-year decrease of 1709.6%. This contributed to the annual value of $3.96 for FY2024, which is 1353.71% down from last year.
  • As of Q3 2025, Utah Medical Products' EPS (Basic) stood at $0.82, which was down 1960.78% from $0.94 recorded in Q2 2025.
  • Utah Medical Products' EPS (Basic)'s 5-year high stood at $1.26 during Q4 2022, with a 5-year trough of $0.82 in Q3 2025.
  • Moreover, its 5-year median value for EPS (Basic) was $1.08 (2023), whereas its average is $1.04.
  • Its EPS (Basic) has fluctuated over the past 5 years, first skyrocketed by 16300.46% in 2021, then plummeted by 2711.86% in 2024.
  • Over the past 5 years, Utah Medical Products' EPS (Basic) (Quarter) stood at $1.13 in 2021, then rose by 11.5% to $1.26 in 2022, then dropped by 6.35% to $1.18 in 2023, then fell by 27.12% to $0.86 in 2024, then decreased by 4.65% to $0.82 in 2025.
  • Its EPS (Basic) was $0.82 in Q3 2025, compared to $0.94 in Q2 2025 and $0.92 in Q1 2025.